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ABSTRACT Ab17-42 (so-called p3) amyloid is detected in vivo in the brains of individuals with Alzheimer’s disease or Down’s
syndrome. We investigated the polymorphism of Ab17-42 oligomers based on experimental data from steady-state NMR
measurements, electron microscopy, two-dimensional hydrogen exchange, and mutational studies, using all-atom molecular-
dynamics simulation with explicit solvent. We assessed the structural stability and the populations. Our results suggest that
conformational differences in the U-turn of Ab17-42 lead to polymorphism in b-sheet registration and retention of an ordered
b-strand organization at the termini. Further, although the parallel Ab17-42 oligomer organization is the most stable of the
conformers investigated here, different antiparallel Ab17-42 organizations are also stable and compete with the parallel architec-
tures, presenting a polymorphic population. In this study we propose that 1), the U-turn conformation is the primary factor leading
to polymorphism in the assembly of Ab17-42 oligomers, and is also coupled to oligomer growth; and 2), both parallel Ab17-42 olig-
omers and an assembly of Ab17-42 oligomers that includes both parallel and antiparallel organizations contribute to amyloid ﬁbril
formation. Finally, since a U-turn motif generally appears in amyloids formed by full proteins or long fragments, and since to date
these have been shown to exist only in parallel architectures, our results apply to a broad range of oligomers and ﬁbrils.INTRODUCTION
Amyloidogenic proteins are characterized by their tendency
to aggregate into b-sheet-rich amyloid fibrils that are associ-
ated with a number of progressive degenerative diseases.
Some of the most devastating diseases affect the central
nervous system, including Alzheimer’s disease (AD),
Parkinson’s disease, Huntington’s disease, prion diseases
(‘‘mad cow’’ disease), amyotrophic lateral sclerosis, and
Down’s syndrome (DS) (1–5), in addition to type II diabetes
mellitus (6).
AD is characterized by the presence of extracellular senile
amyloid plaques and an intraneuronal neurofibrillary tangle
in the brain. Biochemical analysis has revealed that the
main constituent is a small polypeptide, Ab1-40 or Ab1-42,
that is derived from endoproteolytic cleavage of the trans-
membrane amyloid precursor protein (APP) (7). The hydro-
philic residue-rich N-terminus (residues 1–28) is exposed to
the aqueous extracellular environment, whereas the hydro-
phobe-rich C-terminus (residues 29–42) is deeply embedded
in the membrane (8,9). In the so-called ‘‘amyloidogenic
cleavage’’ pathway leading to the production of Ab1-40/
Ab1-42, APP is cleaved in the extracellular domain by
b secretase, whereas g secretase cleaves APP in the trans-
membrane region. In a second pathway, so-called ‘‘nonamy-
loidogenic cleavage’’ (2,10–13), a secretase and g secretase
cleave the APP and yield Ab17-42 (14), the so-called p3.
Thus, in addition to Ab1-40/Ab 1-42, the plaques contain
Ab17-42 fragments. Ab17-42 is prevalent in the brains of
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neuritis, but is absent or sparse in age-matched patients
without AD (non-AD brain) (15). Ab17-42 is also present
in neurotic plaques in individuals with DS (5). The function
and toxic properties of Ab17-42, the importance of its accu-
mulation in AD and DS, and the mechanism behind fibril
formation are still unclear. Although the Ab17-42 fragment
was initially thought to be nonamyloidogenic, in vitro
experiments showed that Ab17-42 fragments can form
amyloid fibrils (15–18) even though the intermediate
soluble oligomeric state may not be stable, and can fibrillate
directly (19).
Studies in humans, wild-type rodents, transgenic mice,
cultured cells, and in vitro systems suggest that soluble, olig-
omeric assembly intermediates of amyloidogenic proteins
are the primary pathogenic effectors (20–22), with most data
obtained for Ab1-42 (23–27). Abundant data from other pro-
teins demonstrate that this is a common mechanism (28–32).
Investigating the structures of oligomers is a challenging task
because of their small size and short-lived nature compared
with mature amyloid fibrils (33,34). On the other hand,
mature fibrils can also be toxic, and the toxicity may also
change with amyloid morphologies (35). This is particularly
the case for brittle fibrils (36). The complexity of the under-
lying mechanisms of amyloid toxicity largely derives from
the interplay of the stabilities, and oligomer and amyloid
fibril variability.
Studies of polymorphism are important because under-
standing the range of potential conformations under various
conditions and the self-assembly mechanism by which
ordered fibrils assemble from the conformational ensemble
doi: 10.1016/j.bpj.2009.05.042
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mentally, polymorphism is well documented in amyloid
formation (18,36–51). Molecular-dynamics (MD) simula-
tions are a useful computational tool to address amyloid
conformational variability (52). In recent studies (53,54),
MD simulations of Ab17-42 were performed based on the
Lu¨hrs model (35) and for Ab1-40 fibrillar architecture
(55,56). In this work, we constructed 14 oligomers with
different backbone conformations due to the U-turn segment
variability, and with a range of b-strand arrangements. We
did not study polymorphism as it relates to side-chain confor-
mations. We performed all-atom MD simulations in explicit
solvent to investigate the polymorphism and conformational
stability of the constructed Ab17-42 oligomers. Analysis of
the conformational stabilities and energies of Ab17-42 oc-
tamer models based on experimental structures presented
two dominant forms, thus indicating that competing poly-
morphic populations already exist at the oligomer level.
MATERIALS AND METHODS
Single- and double-layer models of Ab17-42
The initial coordinates of an Ab17-42 octamer were extracted from the aver-
aged NMR-based structure (PDB code: 2BEG) derived from quenched
hydrogen/deuterium-exchange NMR (35). We extracted the third monomer
conformation of the Ab17-42 peptide from the b-amyloid pentamer and
extended the number of monomers to eight. Initial conformations of the
Ab17-42 octamer were also extracted from the solid-state NMR (ssNMR)-
based model of Ab1-40 (57) (R. Tycko, National Institutes of Health,
personal communication, 2009) by removing residues Gly9-Lys16 and add-
ing residues Ile41 and Ala42 to the C-termini of each monomer. Finally,
initial configurations were also extracted from the Ma-Nussinov computa-
tional model (58). All of the models were used to generate parallel, antipar-
allel, and a combination of parallel and antiparallel organizations of the
Ab17-42 oligomers. Double-layered structural models of Ab17-42 oligomers
were modeled using these organizations. The two b-sheets were associated
together via the C-terminal/C-terminal interface and stacked in an antipar-
allel orientation, with maximum overlap of the hydrophobic region. A total
of 14 octamer models were constructed, including single and double layers,
three turn types, and three parallel/antiparallel organizations, and simulated.
MD simulation procedure
MD simulations of solvated Ab17-42 oligomers were performed in the NPT
ensemble using the NAMD program (59) with the CHARMM27 force field
(60,61). The oligomers were energy-minimized and explicitly solvated in
a TIP3P water box (62,63) with a minimum distance of 10 A˚ from any
edge of the box to any Ab atom. Any water molecule within 2.5 A˚ of the
Ab was removed. Counterions Naþ were added at random locations to
neutralize the Ab17-42 charge. The Langevin piston method (59,64,65)
with a decay period of 100 fs and a damping time of 50 fs was used to main-
tain a constant pressure of 1 atm. A temperature of 330 K was controlled by
a Langevin thermostat with a damping coefficient of 10 ps1 (59). The short-
range van der Waals interactions were calculated using the switching func-
tion, with a twin range cutoff of 10.0 and 12.0 A˚. Long-range electrostatic
interactions were calculated using the particle mesh Ewald method with a
cutoff of 12.0 A˚ (66,67). The equations of motion were integrated using
the leapfrog integrator with a step of 1 fs.
The solvated systems were energy-minimized for 2000 conjugated
gradient steps, and the distance between the b-sheets in Ab17-42 was fixedin the range of 2.2–2.5 A˚. The counterions and water molecules were
allowed to move. The hydrogen atoms were constrained to the equilibrium
bond using the SHAKE algorithm (68). The minimized solvated systems
were energy-minimized for an additional 5000 conjugate gradient steps at
250 K, with all atoms allowed to move. Then the systems were heated
from 250 K to 300 K for 300 ps and equilibrated at 330 K for 300 ps. All
simulations ran for 30 ns. These conditions were applied to test the stabilities
of all Ab17-42 oligomers.
Analysis details
To obtain the relative structural stability of the Ab17-42 oligomers, the Ab
trajectories of the last 5 ns were first extracted from the explicit MD simu-
lation, excluding water molecules. Fig. S1 and Fig. S2 in the Supporting
Material present two examples of the structural stabilities of Ab17-42 oligo-
mers. The solvation energy of each system was calculated using the gener-
alized Born method with molecular volume (GBMV) (69,70). Details on the
GBMV method are provided in the Supporting Material.
We further examined the stability of the oligomers by following the
changes in the number of hydrogen bonds between the b strands with the
hydrogen bond cutoff set to 2.5 A˚, and by monitoring the change in the in-
tersheet distance (Ca backbone-backbone distance) in the core domain of all
of the oligomers. The core domain is explained in detail in the Supporting
Material.
RESULTS AND DISCUSSION
Construction of the conformational ensemble
of Ab17-42 octamers
To compare potential oligomers that would be expected to
relate to the ensuing amyloid fibril variants, we constructed
a conformational ensemble of 14 initial arrangements and
generated 500 conformations for each arrangement by MD
simulation.
First, we chose three monomeric conformations based on
experimental data and computational results. Two experi-
ment-based models of the three-dimensional structures of
Ab oligomers were recently obtained: the first, called the
Lu¨hrs model (35), presents a parallel single-layer structure
of Ab1-42 oligomers based on hydrogen/deuterium-exchange
NMR data, combined with side-chain packing constraints
from pairwise mutagenesis, ssNMR, and high-resolution
cryo-electron microscopy (PDB code: 2BEG); the second,
called the Tycko model (57), exhibits a parallel double-layer
structure of Ab1-40 fibrils based on ssNMR. A third compu-
tational model, proposed by Ma and Nussinov (58), predicts
a parallel structure for Ab10-35. According to all three of
these models, the buried salt bridge (residues Asp23-Lys28)
stabilizes the U-turn. In addition, they suggest that parallel
oligomers are associated in a parallel orientation to form
the Ab fibrils. The main difference between these three
models is the slight variation in the U-turn location and
size in the Ab peptide (Ser26-Ile31 for the Lu¨hrs model,
Asp23-Gly29 for the Tycko model, and Val24-Asn27 for the
Ma-Nussinov model), and therefore in the turn shape. The
U-turn bent b-sheet of the Ma-Nussinov computational
model is similar to that of the Tycko model.
To select conformations with the most likely arrangements
and keep the number of arrangements manageable withBiophysical Journal 97(4) 1168–1177
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three main types of variability in oligomer conformations: 1),
b-strand backbone alignments in parallel and/or antiparallel
orientations; 2), slight changes in backbone conformations
due to variation in the turn; and 3), a change in association
due to different matches of the b-sheet layers. Table 1 and
Table S1 list the three arrangements of tested octamers and
their overall features.
We start by comparing parallel and antiparallel alignments
using single-layer octamers (Fig. 1). The first two models,
M1 (Fig. 1 A) and M2 (Fig. 1 B), are parallel; here our
goal is to reproduce the experimental conformations with
the full-length Ab peptides used by Tycko and Lu¨hrs, respec-
tively. Six other arrangements with antiparallel b-strands in a
single layer are constructed as reference states. M7 (Fig. 1 C
and Fig. S3) and M9 (Fig. S4) use four parallel dimers asso-
ciated in an antiparallel arrangement to form a b-sheet oc-
tamer based on Lu¨hrs and Tycko’s monomers, respectively.
M10 (Fig. 1D and Fig. S5), M12 (Fig. 1 E and Fig. S3), M13
(Fig. 1 F and Fig. S4), and M14 (Fig. S4) are models with all
b-strands organized in antiparallel alignments. Side-chain
registration in the antiparallel alignments is selected to maxi-
mize the backbone hydrogen bonds and the hydrophobic
core within the b-sheets (M10 and M11), although a model
with less backbone hydrogen bonds but more compact turn
interactions is also tested (M13).
Six models with double-layer arrangements (dimer of
tetramers; Fig. 2 and Fig. S3 and Fig. S5) are also tested to
explore variations in the associations of oligomers, focusing
on a comparison of different matches of b-sheet layers. M3
(Fig. 2 A) can be viewed as a double layer of M1 (Fig. 1 A).
M4 (Fig. 2 C), M5 (Fig. 2 D), and M6 (Fig. 2 B) are stacked
forms of M2 (Fig. 1 B). M3 and M6 have similar hydro-
phobic interactions between two layers. However, since the
turns are different for M3 and M6, the M3 model has a largercontact surface between the two layers. The M4 and M5
models shift the side-chain registration between the two
layers as compared with the M6 model. However, the differ-
ence between the M4 and M5 hydrophobic contacts is small.
Finally, M8 (Fig. 2 E and Fig. S3) tests the double-layer form
of M7 (Fig. 1 C and Fig. S3), and M11 (Fig. S5) is the
double-layer form of M10 (Fig. 1 D and Fig. S5).
Using the models described above, we can examine the
effects of the backbone turn conformation in a single layer
by comparing M1 with M2; M3 with M4; and M10, M12,
and M13 (Table 1 and Table S1).
Conformational stability of parallel Ab17-42
oligomers: polymorphic U-turn shapes
and hydrophobic association
For the single-layer structure, both Tycko’s and Lu¨hrs’
conformers associate into a stable b-sheet whereas the turn
region remains flexible. Backbone and U-turn root mean-
square deviations (RMSDs) indicate that the parallel
conformers M1 and M2 are stable (Fig. S6). In addition,
analysis of the averaged Asp23-Lys28 distance in M1 and
M2 indicates that the salt bridge in these conformers is
also stable (Fig. S7). M1 has a slightly better association
among the b-strands assisted by backbone hydrogen bonds
(Fig. 3 A). The b-sheet distances (Ca backbone–backbone
distance; Fig. 3 C) within the U-turn expand to ~14–15 A˚,
which is relatively large in comparison with the mostly
packed association in the mature fibrils (~10–11 A˚). This
expansion indicates that the turn region is still not locked
in either the M1 or M2 model at the octamer level. However,
M1 has a slightly tighter turn region, and thus has slightly
more backbone hydrogen bonds than M2. The energy differ-
ence between M1 and M2 is very small (Table 1). Even
though for the conformers sampled, M1 has slightly lowerTABLE 1 Constructed Ab17-42 oligomers based on the Lu¨hrs (35), Tycko (57), and Ma-Nussinov (58) models, including single and
double layers
Model* number Model Conformational structure Layer
Conformational energyy
(kcal/mol) Populationz (%) Figure
M1 Tycko Parallel Single 2287.88 (104.78) 12 1 A
M2 Lu¨hrs Parallel Single 2244.66 (103.01) 12 1 B
M3 Tycko Parallel Double 2170.56 (102.45) 10 2 A
M4 Lu¨hrs Parallel 1 Double 2172.05 (106.88) 10 2 C
M5 Lu¨hrs Parallel 2 Double 2135.91 (107.65) 9 2 D
M6 Lu¨hrs Parallel 3 Double 2005.83 (100.95) 5 2 B
M7 Lu¨hrs Parallel dimers associated in antiparallel Single 2074.97 (106.19) 7 1 C and Fig. S3
M8 Lu¨hrs Parallel dimers associated in antiparallel Double 2114.67 (103.83) 5 2 E and Fig. S3
M9 Tycko Parallel dimers associated in antiparallel Single 1961.70 (105.06) 4 Fig. S4
M10 Ma- Nussinov Antiparallel Single 2112.22 (101.79) 8 1 D and Fig. S5
M11 Ma- Nussinov Antiparallel Double 2095.03 (99.54) 7 Fig. S5
M12 Lu¨hrs Antiparallel Single 1966.88 (104.04) 4 1 E and Fig. S3
M13 Tycko Antiparallel 1 Single 1970.76 (93.14) 4 1 F and Fig. S4
M14 Tycko Antiparallel 2 Single 1909.77 (106.38) 3 Fig. S4
*Model 1; see Table S1 for variation classification.
yConformational energies were computed using the GBMV calculations (69,70). Standard deviation values are presented in parenthesis.
zPercentage of populations or the relative probabilities of the conformational structures were computed using MC simulations.
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Polymorphism of A-b17-42 1171FIGURE 1 Initial structural models of single-layer Ab17-
42 oligomers. Parallel: (A) Tycko’s model M1 and (B)
Lu¨hrs’ model M2. Antiparallel: (C) Lu¨hrs’ model M7,
(D) Ma-Nussinov’s model M10, (E) Lu¨hrs’ model M12,
and (F) Tycko’s model M13.average energies than M2, the difference is within the SD. In
conclusion, for a single layer, the two experimental models
with different U-turn shapes show a similar behavior and
are similar in energies, indicating polymorphic parallel
single layers of Ab17-42 oligomers.
In theM3 andM6 double-layer structures (Fig. 2, A and B),
two b-sheets are stacked against each other in a twofold
symmetry-like orientation with distinct C-terminal/
C-terminal interfaces. In comparison with alternate associa-
tions (N-terminal to C-terminal, or N-terminal to N-terminal)
this orientation was found to be the most stable because it
provided maximized hydrophobic interactions (53). Appar-
ently, the double-layer structures further rigidify the turn, as
seen in Fig. 3D, where the double layers have similar b-sheet
distances (Ca backbone–backbone distance) within the
U-turn in the single-layer model (Fig. 3 C), but with smalleroverall RMSD (Fig. S6 and Fig. S8). Backbone and U-turn
RMSDs exhibit stable structures (Fig. S8). In addition, anal-
ysis of the averaged Asp23-Lys28 distance in the parallel
conformers M3 and M4 indicates the stability of the salt
bridge in these studied conformers (Fig. S9). At the octamer
level, the formation of double-layer structures sacrifices the
backbone hydrogen bonds, as indicated by the smaller
percentage of hydrogen bonds (Fig. 3 B) compared with the
single-layer models (Fig. 3 A). The gain of hydrophobic inter-
actions from the formation of the double-layer structure is still
insufficient to offset the loss of backbone hydrogen bonds.
Therefore, as seen in Table 1, the single-layer conformers
of both models M1 and M2 have lower energy compared to
the constructed models of the double layers M3 and M6 (as
well as M4 and M5). For oligomers larger than those studied
here, double layers should be more stable than single layers.FIGURE 2 Initial structural models of double-layer
Ab17-42 oligomers: (A) Tycko’s model M3 (B) Lu¨hrs’
model M6, (C) Lu¨hrs’ model M4, (D) Lu¨hrs’ model M5,
and (E) Lu¨hrs’ model M8.
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1172 Miller et al.FIGURE 3 Fraction of the number of hydrogen bonds
(in percentage) between all b-strands compared with the
initial Ab17-42 oligomer parallel conformation for (A) a
single layer of Tycko’s model M1 (blue) and Lu¨hrs’ model
M2 (red), and (B) a double layer of Tycko’s model M3
(blue), Lu¨hrs’ model M4 (red), and Lu¨hrs’ model M6
(green). (C) Ca backbone–backbone distance of the single
layer for Tycko’s model M1 (blue) and Lu¨hrs’ model
M2 (red). (D) Ca backbone–backbone distance of the
double layer for Tycko’s model M3 (blue), Lu¨hrs’ model
M4 (red), and Lu¨hrs’ model M6 (green).At first glance, a comparison between the double layers of
the two conformers M3 and M6 shows that Tycko’s
conformer M3 is preferred over Lu¨hrs’ M6 (Table 1), due
to the strong hydrophobic interactions between the two
b-sheets of the two layers (Fig. 2, A and B). The sheet-to-
sheet packing is stabilized by a nonpolar zipper through
van der Waals and hydrophobic interactions. The double-
layer conformer constructed based on Lu¨hrs’ model M6
(Fig. 2 B) has hydrophobic interactions between the
C-termini of the two layers (Ile31 interacting with Met35)
similar to those observed in the conformer constructed using
Tycko’s model M3 (Fig. 2 A). However, in M6 the overlap of
the hydrophobic region (Ile31-Ile41) at the C-terminal/
C-terminal interface is small. This indicates that a different
U-turn shape can affect the hydrophobic associations
between two layers. Two different double-layer models
based on the Lu¨hrs turn structure (M4 and M5) attempt to
maximize the overlap of this hydrophobic region, involving
hydrophobic interactions between Ile31-Ile41 and Met35-
Met35 at the C-terminal/C-terminal interface (Fig. 2, C and
D) (53). As a result, both M4 and M5 are significantly lower
in energy than M6, and the M4 conformer is the most stable
conformer among these three conformers. The GBMV
energy of the M4 conformer is fairly similar to Tycko’s
double-layered conformer M3 (Fig. 2 A, Table 1). This simi-
larity indicates that two double-layer Ab17-42 structures
based on the different U-turn shapes also have similar stabil-
ities, and consequently further confirms a likely polymorphic
scenario in amyloid formation.
Conformational stability of nonparallel
Ab17-42 oligomers
Although parallel Ab1-40 and Ab1-42 oligomers are stable in
experiment and simulations, there are no experimental data
Biophysical Journal 97(4) 1168–1177with a similar resolution for the p3 (Ab17-42); only low-
resolution electron microscopy images are available (18).
ssNMR suggests a stable Ab16-22 antiparallel b-sheet organi-
zation (71) and a mixed picture for Ab25-35 (72). Focusing on
stability and populations, we tested other architectures based
on the experimental Tycko and Lu¨hrs oligomers.
We modeled two octamers, each consisting of four parallel
dimers associated in an antiparallel orientation. The first
octamer is based on the Lu¨hrs model (M7; Fig. 1 C and
Fig. S3), and the second on Tycko’s model (M9; Fig. S4).
We obtained the conformer populations by means of
GBMV calculations and Monte Carlo (MC) simulations,
and the results show that the Lu¨hrs conformer is the preferred
dimer model for the antiparallel orientation (Table 1). The
octamer based on Tycko’s model (M9) is disfavored due to
the small number of hydrogen bonds between the b-strands
of the monomers as compared to the Lu¨hrs model. Fig. 4 A
describes the change in the number of hydrogen bonds
between the b strands in the single layer of the Lu¨hrs model
(M7) during the simulations. For the octamer modeled as
four dimers associated in antiparallel orientation, >50% of
the hydrogen bonds are retained during the 30 ns simula-
tions. The change in the intersheet distance across the cavity
is shown in Fig. 4 B for this conformer. The intersheet
distance is in the range of 12–13 A˚, indicating that the turn
region is more rigid in the antiparallel alignment.
A second set of antiparallel octamers was built by alter-
nating single monomers (M10, M12, M13, and M14). The
antiparallel b-sheets organization of the monomers was
modeled using both the experimental models and the Ma-
Nussinov computational model. Fig. 1, D–F, show single
layers of three octamer models of the Ab17-42 antiparallel
organization. Of interest, both the Tycko (M13 and M14)
and Lu¨hrs (M12) models show similar energy values
Polymorphism of A-b17-42 1173FIGURE 4 (A) Fraction of the number of hydrogen
bonds (in percentage) between all b-strands compared
with the initial single-layer M7 (blue) Ab17-42 oligomer
shown in Fig. 1 C, and double-layer M8 (red) Ab17-42 olig-
omer shown in Fig. 2 E. (B) Ca backbone–backbone
distance of the single-layer M7 (blue) Ab17-42 oligomer
shown in Fig. 1 C, and double-layer M8 (red) Ab17-42 olig-
omer shown in Fig. 2 E.obtained in the GBMV calculations (Table 1). The antipar-
allel model based on the Ma-Nussinov computational model
(M10) shows a higher stability and higher population
compared to the experimental models (Table 1). This is the
outcome of more hydrogen bonds and hydrophobic interac-
tions as compared to the experimental models (Fig. 1, D–F).
Yet, all the antiparallel models tested have higher energies
than the parallel models.
The constructed double layer of the preferred octamer for
dimers associated in an antiparallel orientation based on the
Lu¨hrs model (M8; Fig. 2 E). This double-layer model is more
stable than the single-layer model M7, despite the small olig-
omer size. Apart from the hydrogen bonds between the
b-strands of the monomers as in the single layer, the double
layer also possesses hydrophobic interactions between the
two layers, which increases the oligomers’ stability. Another
double-layer model (M11) with antiparallel b-strand align-
ment is not more stable than the corresponding single-layer
model (M10). However, the energy difference between the
single layer and the double layer is small. Taken together
with the M8 conformer, the preference for single-layer olig-
omers holds only for small parallel b-sheet conformers.
Polymorphic of Ab17-42 oligomers: energy
and populations
Using all 14 models and 7000 conformations (500 for each
model) generated through MD simulations, we estimate the
overall populations for each model based on MC simulations
with the energy landscape computed with GBMV for all
conformers. For the complex kinetics of amyloid formation,
this group is likely to represent only a very small percentage
of the ensemble. Nevertheless, the carefully selected models
cover the most likely organizations. The population results
are reported in Table 1.
The most striking observation from these calculations is
the equal populations of the parallel models constructed
with Tycko and Lu¨hrs’ structures at both the single-layer
(M1 and M2) and double-layer (M3 and M4) level, despite
the small energy difference found when we examine the
average energies for each model. The fact that the two
parallel models that differ in the U-turn conformation exhibit
similar populations for both single and double layers
strongly supports the notion that the type of U-turn may bea primary characteristic of the polymorphism of mature
Ab17-42 fibrils.
For the Ab17-42 oligomers, the parallel conformers had the
highest population of all the conformers studied here.
Furthermore, apart from the parallel organization, antipar-
allel Ab17-42 oligomers are also populated. Here, the most
stable conformer was obtained based on the Ma-Nussinov
computational model. The energy difference between this
conformer and both experimental models for the single layer
is ~140 kcal/mol (Table 1). The computed model is more
stable due to the tightly packed b-sheets, compared with
the experimental models in which such tightly packed
conformations are not observed. As shown in Fig. 1 D and
Fig. S5, the antiparallel Ab17-42 oligomer based on the
computational model involves strong hydrophobic interac-
tions (e.g., between Leu and Phe) that are not observed in
the two experimental models (Figs. 1, E and F, and
Fig. S3 and Fig. S4). The population size of the computa-
tional model is also higher. Other studied organizations
consist of parallel dimers associated in an antiparallel orien-
tation. The Lu¨hrs conformer exhibits the largest stability and
the highest population (Table 1), due to the tightly packed
b-sheets (Figs. 1 C and 2 E).
Conformational differences in the U-turns between the
Tycko and Lu¨hrs models can lead to polymorphism as
reflected in sheet–sheet registration and the extent of
ordered/disordered b-strand organization at the termini for
full-length Ab1-40/Ab1-42. In Tycko’s model, residues 1–9
are structurally disordered, residues 10–22 and 30–40 form
b-strands, and residues 23–29 form a turn. In Lu¨hrs’ model,
residues 1–16 are disordered, and residues 17–26 and 31–42
form b-strands that are connected by a four-residue (27–30)
U-turn. Both Ab1-40/Ab1-42 models present parallel sheet
organization; however, the different turn shape is reflected
in their polymorphic behavior. Our results regarding the
relative conformational stabilities and populations demon-
strate that the major characteristics of the full-length Ab1-40/
Ab1-42 models have been preserved in the Ab17-42 amyloid
formation.
Thus, it appears that more than one parallel conformer of
the Ab17-42 oligomer is responsible for p3 amyloid fibril
formation. Previous ssNMR measurements (43) of the amy-
lin fibril responsible for type II diabetes suggest a similar
scenario. In summary, it is not only one conformation thatBiophysical Journal 97(4) 1168–1177
1174 Miller et al.fibrillates; rather, there exists a conformational variability in
a range of different populations, including amorphous aggre-
gates in dynamics equilibrium. A broad repertoire of turn
conformations and side-chain orientations may lead to poly-
morphic oligomers and fibrils. Which ones prevail is likely to
depend on the conditions, e.g., sequence such as mutational
variants, length, concentration, pH, ionic strength, and tem-
perature, presence of various ligands and solutes, and dif-
ferent surface properties. Using MD simulations, Takeda
and Klimov (73) investigated the binding of Ab peptides
to amyloid fibril and found that Ab peptides may associate
with fibrils, forming elements of parallel and antiparallel
organizations with similar preferences.
CONCLUSIONS
Using all-atomMD simulations in explicit solvent, we inves-
tigated polymorphic architectures for Ab17-42, which is
cleaved by a secretase from Ab1-42 in vivo and is associated
with AD and DS. Several monomers and oligomer organiza-
tions were studied. These were based on experimental
models developed by Tycko and co-workers (57) and Lu¨hrs
et al. (35). Although both presented a parallel assembly, this
does not rule out other potential assemblies whose popula-
tions are too low to be detected under our particular experi-
mental conditions. Indeed, the Lu¨hrs and Tycko structures
differed in their turn conformations, pointing to fibril poly-
morphism. Furthermore, these experimental models were
for Ab1-40/Ab1-42, whereas the truncated Ab17-42 monomers
can potentially display different preferred conformational
states. No relatively high-resolution experimental structure
is available for Ab17-42, and no simulations of its potential
architectures have been performed. Since oligomers are a
toxic species and constitute the fibril seeds, we focused
here on their stabilities and populations. Although we did
not investigate such factors in this study, it behooves us to
emphasize that amyloid fibril formation depends not only
on nucleation and kinetics, but also on conditions such as
temperature, concentration, and pH.
The major conclusion drawn from this study is that the
U-turn conformation is the primary factor in amyloid poly-
morphism for Ab17-42. Previous studies have confirmed
that the Asp23-Lys28 salt bridge plays an important role in
turn stability. Melquiond et al. (74) studied the role of the
stability of Asp23-Lys28 in Ab fibril formation. The Ma-
Nussinov model (58) similarly suggests that the salt bridge
stabilizes the oligomer and can play a role in Ab oligomer
formation. In the Ab1-40 (57) oligomer structure, the
Asp23-Lys28 salt bridge is intramolecular, whereas in Ab1-42
(35) the Asp23-Lys28 salt bridge is intermolecular. The
stability of the Asp23-Lys28 in Ab fragments has been
studied previously (75,76,77). Thus, in this work we did
not focus on the stabilizing effect of the salt bridge; rather,
we examined the difference in the U-turn shapes of these
two experimental models and its contribution to the oligomerBiophysical Journal 97(4) 1168–1177variation. These distinct turn shapes (and probably many
others for which no experiment-based coordinates are
currently available) lead to oligomer polymorphism as the
positions of the sheets, the sheet–sheet interactions, and the
consequent lengths of the disordered N-terminals are altered.
We also found out that the difference in the U-turn shape
is coupled with the way two layers of b-sheet oligomers
associate into a larger double-layer oligomer. This issue is
well illustrated by the double-layer models M3 and M4,
which have different U-turn shapes and different hydro-
phobic patterns of association. Thus, for a given U-turn
type, different hydrophobic association patterns can lead to
polymorphism with large differences in energy and popula-
tions (e.g., M4 and M6), or with small differences in energy
and populations (e.g., M4 and M5).
Although the population of an antiparallel b-strand organi-
zation is not negligible, our results demonstrate that the
parallel Ab17-42 oligomer is the most stable organization,
and the conformer that was modeled using Tycko’s model
(57) is slightly preferred over Lu¨hrs’ model for the single
layer (35). On the other hand, for the double layer, both
models have similar stabilities (a difference of ~2 kcal/mol).
The main difference between these two experimental
models is in the U-turn shape. The turn determines the inter-
sheet registration. Therefore, the U-turn conformation plays
a key role in the stability and polymorphic conformational
ensemble of parallel Ab17-42 oligomers. Furthermore,
in vivo the amyloid fibril is a supramolecular structure
composed of several protofibrils that wind around each
other, mostly with a left-handed twist along their main axis
(78–87). Different U-turn conformations can affect the twist
angles and thus lead to different morphologies in electron
microscopy measurements. We therefore conclude that
Ab17-42 conformers with different U-turn shapes and hence
different morphologies can be detected by experiment. It is
important to note here that these may only present the pre-
vailing organization under experimental conditions, and the
probability of detecting the various morphologies will
depend on the size of the population. In general, for longer
sequences, a parallel organization is favored because iden-
tical residues stack on top of each other and the identical
charge repulsion at the terminals is overcome (88). We
further emphasize that it remains to be determined which
organizations preferentially interact with and penetrate the
bilayer; however, the question is relevant because interaction
with the bilayer is currently believed to underlie toxicity.
Insights into polymorphic behavior at the molecular level
should assist investigators in understanding the mechanism
of aggregation and toxicity, and may pave the way to novel
therapeutic approaches and more effective drug design.
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